This multicenter, open-label study evaluated the efficacy and safety of decitabine in patients from Argentina and South Korea with myelodysplastic syndromes or chronic myelomonocytic leukemia. 该研究为多中心、开放性研究。在来自阿根廷和韩国的骨髓增生异常综合征或慢性粒-单核细胞白血病患者中,评估了地西他滨的疗效与安全性。
The Clinical Study of Chronic Myelomonocytic Leukemia(CMML) 慢性粒-单核细胞白血病的临床分析